Skip to main content
. 2010 Dec 14;16(46):5881–5888. doi: 10.3748/wjg.v16.i46.5881

Figure 2.

Figure 2

Progression-free survival time of patients with or without KRAS mutation (A) and phosphatase and tensin protein expression (B). A: P < 0.001; B: P = 0.07. PFS: Progression-free survival.